ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,869,000 | -53.5% | 125,399 | -50.8% | 0.30% | -59.0% |
| Q1 2017 | $12,620,000 | -22.1% | 254,889 | -4.6% | 0.72% | -37.5% |
| Q4 2016 | $16,192,000 | +2011.1% | 267,100 | +2210.4% | 1.15% | +2202.0% |
| Q3 2016 | $767,000 | -79.5% | 11,561 | -82.8% | 0.05% | -80.8% |
| Q2 2016 | $3,749,000 | -2.3% | 67,161 | -41.1% | 0.26% | -22.8% |
| Q1 2016 | $3,839,000 | +564.2% | 114,060 | +791.1% | 0.34% | +683.7% |
| Q4 2015 | $578,000 | -62.0% | 12,800 | -66.8% | 0.04% | -29.5% |
| Q3 2015 | $1,522,000 | -92.5% | 38,512 | -88.2% | 0.06% | -95.0% |
| Q2 2015 | $20,300,000 | +5.4% | 327,157 | +6.3% | 1.22% | -18.3% |
| Q1 2015 | $19,252,000 | +9.2% | 307,784 | -1.5% | 1.50% | +1.2% |
| Q4 2014 | $17,622,000 | +1148.9% | 312,500 | +594.4% | 1.48% | +898.6% |
| Q1 2014 | $1,411,000 | – | 45,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |